Exclusive Interviews

Dr. Paresh Dandona, Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Buffalo, The State University of New York, continues his discussion with Associate Medical Editor Joy Pape at the 2015 ADA Sessions in Boston. This week, he shares his thoughts on the greatest advancements in diabetes care.

Dr. Paresh Dandona, Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Buffalo, The State University of New York, joins Associate Medical Editor Joy Pape in a discussion at the 2015 ADA Sessions in Boston regarding highlights of his presentation, "GLP-1 Receptor Agonists as Adjunctive Treatment in Type 1 Diabetes."

This week, Associate Medical Editor Joy Pape wraps up her discussion with R. Keith Campbell, MBA, at the 2015 ADA Sessions in Boston. In this segment, he talks about his 60+ years of experience as a type 1 diabetes patient and how what he has learned over the years influences his view of his diabetes today.

This week, Associate Medical Editor Joy Pape continues her discussion with R. Keith Campbell, MBA, at the 2015 ADA Sessions in Boston. In this segment, he shares his advice with other healthcare providers in regards to how to help their patients. He advocates for patient education now to mitigate the expensive complications that could happen later.

This week, Associate Medical Editor Joy Pape meets with R. Keith Campbell, MBA, professor emeritus of Diabetes Care/Pharmacology at Washington State University at the 2015 ADA Sessions in Boston to discuss the latest interesting developments in diabetes care and management.

This week we have the second part of our two-art interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell, and we delve a little deeper into the specifics of this new technology to heal chronic wounds using placental biomaterials. Steve Freed: With all the testing that is …

This week we are excited about our exclusive interview with Dr. Janice Smiell, CMO at Alliqua BioMedical, Inc. Dr. Smiell and her team have been doing some groundbreaking work on battling chronic wounds using placental biomaterials. Steve Freed:  Welcome, Dr. Janice Smiell. Let’s begin by having you tell us a …

Steve Freed: Please tell us a little about yourself and this new compound, BTI320. Dr. David Platt: My area of expertise is the recognition between carbohydrate and protein. In my previous two companies, I developed drugs for a recognition between sugar and protein. In one case, it was a protein that …

Steve Freed: Let’s start out with a little background about Qsymia and Belviq. What is the FDA allowing you to treat with the drugs? Dr. Timothy Garvey: In 2012, the FDA approved two new weight loss medications. In 2014, another medication was approved. That is three new medications. We hope …

Steve Freed, Publisher, Diabetes in Control: When do you think you might be able to submit to the FDA? Joe Cook, Jr: Having developed a number of medicines, they all have their own character. It’s like children. They all come with different presentations. If the data from this study are very clear …